Angel Biotechnology Holdings (LSE:ABH) ROC %: -348.31% (As of Sep. 2012)


What is Angel Biotechnology Holdings ROC %?

Angel Biotechnology Holdings LSE:ABH ROC % is -348.31% as of Sep. 2012. The stock has 2 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Angel Biotechnology Holdings's annualized return on capital (ROC %) for the quarter that ended in Sep. 2012 was -348.31%.

As of today (2026-06-26), Angel Biotechnology Holdings's WACC % is 0.00%. Angel Biotechnology Holdings's ROC % is 0.00% (calculated using TTM income statement data). Angel Biotechnology Holdings earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Angel Biotechnology Holdings  (LSE:ABH) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Angel Biotechnology Holdings's WACC % is 0.00%. Angel Biotechnology Holdings's ROC % is 0.00% (calculated using TTM income statement data). Angel Biotechnology Holdings earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Angel Biotechnology Holdings ROC % Related Terms

Angel Biotechnology Holdings ROC % Historical Data

* Premium members only.

The historical data trend for Angel Biotechnology Holdings's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Angel Biotechnology Holdings ROC % Chart

Angel Biotechnology Holdings Annual Data
Trend Dec02 Dec03 Dec04 Dec05 Dec07 Dec08 Dec09 Dec10 Mar12
ROC %
Get a 7-Day Free Trial Premium Member Only -49.20 -122.52 -55.45 17.40 -77.34

Angel Biotechnology Holdings Semi-Annual Data
Jun05 Dec05 Jun06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Mar12 Sep12
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.19 19.61 -34.45 0.00 -348.31

Angel Biotechnology Holdings ROC % Calculation

Angel Biotechnology Holdings's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2012 is calculated as:

ROC % (A: Mar. 2012 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2010 ) + Invested Capital (A: Mar. 2012 ))/ count )
=-1.266 * ( 1 - 0% )/( (1.538 + 1.736)/ 2 )
=-1.266/1.637
=-77.34 %

where

Invested Capital(A: Dec. 2010 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1.568 - 0.378 - ( 0.613 - max(0, 1.493 - 1.145+0.613))
=1.538

Invested Capital(A: Mar. 2012 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2.699 - 0.383 - ( 0.58 - max(0, 0.76 - 1.706+0.58))
=1.736

Angel Biotechnology Holdings's annualized Return on Capital (ROC %) for the quarter that ended in Sep. 2012 is calculated as:

ROC % (Q: Sep. 2012 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2012 ) + Invested Capital (Q: Sep. 2012 ))/ count )
=-5.714 * ( 1 - 0% )/( (1.736 + 1.545)/ 2 )
=-5.714/1.6405
=-348.31 %

where

Invested Capital(Q: Mar. 2012 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2.699 - 0.383 - ( 0.58 - max(0, 0.76 - 1.706+0.58))
=1.736

Invested Capital(Q: Sep. 2012 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2.482 - 2.206 - ( 0.496 - max(0, 2.464 - 1.195+0.496))
=1.545

Note: The Operating Income data used here is two times the semi-annual (Sep. 2012) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of -348.31% mean?
Angel Biotechnology Holdings (LSE:ABH) has a ROC % of -348.31% as of Sep. 2012. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Angel Biotechnology Holdings and its competitors.
Is Angel Biotechnology Holdings' ROC % too high?
Angel Biotechnology Holdings' current ROC % is -348.31%.
How does Angel Biotechnology Holdings' ROC % compare to competitors?
Angel Biotechnology Holdings' ROC % of -348.31% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Biotechnology company?
A good ROC % depends on the Biotechnology industry context. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Angel Biotechnology Holdings and its competitors. Angel Biotechnology Holdings's current ROC % is -348.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Angel Biotechnology Holdings stock overvalued right now?
Angel Biotechnology Holdings (LSE:ABH) has a current ROC % of -348.31%. The current ROC % is -348.31%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Angel Biotechnology Holdings (LSE:ABH), the current ROC % is -348.31% as of Sep. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.